Meet Margie. Margie Ruttenberg is a 48-year-old two time blood cancer survivor who believes in hope. Initially diagnosed with Hodgkin lymphoma in 2009, Margie is currently back in treatment.
I was NOT one of the lucky ones successfully treated with my first or second rounds of chemotherapy. But, even after standard chemo failed AND a stem cell treatment did not work, I still have hope. I am taking a newly approved drug that has put patients into remission. I believe this new therapy will finally put me in the SURVIVOR column!
Over the past six years, the survival rate for people with Hodgkin lymphoma has more than doubled to 86%.
I hope for remission this time and that this new therapy will keep me there. I am grateful. I am lucky.
Last year The Leukemia & Lymphoma Society (LLS) invested $3.2 million in Hodgkin lymphoma research. Since its inception, LLS has invested $814 million in research to find more effective, safer treatments for blood cancer patients.
Research means hope. Hope that if you are not cured with one treatment, another is just around the corner. Survival rates only increase when new and better treatments, like mine, become available. That only happens through research and trials - and these are made possible by funding.
LLS currently funds 380 research projects in 12 countries around the globe. With no government support, each project relies on people's generosity to continue.
With this new drug, I have made a sharp turn onto Hope Road. I have been here before but, each time, have been hit by a truck driven by Mr. Hodgkin. Being back on Hope Road is both wonderful and scary. I hope Mr. Hodgkin's license has been revoked, but to be sure would you all go pop his tires?
A gift to LLS is a gift of hope for Margie and the more than one million Americans living with blood cancer. Please continue your support our mission for a cure by making an online donation (In the special handling instructions, please mention "Margie-NCA").
I want to support Margie and fund life-saving research by making the following contribution online:
$250Helps supply researchers with supplies critical to carrying out their search for cures.
$500 Provides three blood cancer patients financial aid to support medical treatment and travel to medical appointments for one year.
$1000 Provides one week's salary for a medical researcher at NIH, Johns Hopkins or George Washington University who may discover key information for developing curative treatments for blood cancers.
On behalf of the patients and families that we serve, thank you for your kind and generous support.